Alcázar-Córcoles MÁ

Department of Biological and Health Psychology, School of Psychology, Autonomous University of Madrid (UAM), Madrid, Spain.

9 papers · ORCID

ArticleAyahuasca

Ayahuasca and Public Health III: Health Status of a Sample of Ayahuasca Ceremony Attenders in Portugal.

Teixeira PJ, Encantado J, Amaro HD +7

Europe PMC2026
ArticleAyahuasca

Personality, not cognition, distinguishes chronic ayahuasca and cannabis users from non-users.

Bouso JC, Andión O, Estévez SF +6

Europe PMC2026
ArticleIbogaine

The Ibogaine Experience Scale (IES): Development and psychometric properties of a multidimensional measure of ibogaine's subjective effects.

González Espejito F, Esteban Rodríguez L, Pedrero Pérez EJ +7

Europe PMC2025
ArticlePsychedelics

Hallucinations and Hallucinogens: Psychopathology or Wisdom?

Bouso JC, Ona G, Kohek M +4

Europe PMC2023
ArticleIbogaine

Underground ibogaine use for the treatment of substance use disorders: A qualitative analysis of subjective experiences.

Rodríguez-Cano BJ, Kohek M, Ona G +4

Europe PMC2023
ArticlePsilocybin

Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study.

Révész D, Ona G, Rossi GN +5

Europe PMC2021
ArticleAyahuasca

Effects of ayahuasca on mental health and quality of life in naïve users: A longitudinal and cross-sectional study combination.

Jiménez-Garrido DF, Gómez-Sousa M, Ona G +4

Europe PMC2020
ArticlePsilocybin

Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.

Dos Santos RG, Bouso JC, Alcázar-Córcoles MÁ +1

Europe PMC2018
ArticleAyahuasca

Measuring the subjective: revisiting the psychometric properties of three rating scales that assess the acute effects of hallucinogens.

Bouso JC, Pedrero-Pérez EJ, Gandy S +1

Europe PMC2016